Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. They are known for their leadership in muscle biology and mechanics. The company is dedicated to empowering its employees and communities to develop potential medicines for diseases involving impaired muscle function.

- Leader in muscle biology and muscle performance - Developing small molecule drug candidates - Focus on diseases with compromised muscle performance - Empowerment in developing potential medicines